跳至主要内容
临床试验/NCT06342219
NCT06342219尚未招募不适用

Study Protocol for a Randomized Controlled Trial of Neurofeedback Mindfulness in Chronic Migraines

University of Saskatchewan2 个研究点 分布在 1 个国家目标入组 135 人开始时间: 2024年12月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
135
试验地点
2
主要终点
Migraine Disability

研究概览

简要总结

As the second phase of our study on migraine headaches and neurofeedback mindfulness, we will explore how chronic migraineurs will benefit from a long term practice (8 weeks) of neurofeedback mindfulness compared to a similar attention group and a waitlisted group. This randomized controlled trial will also explore if migrianuers could decrease their dependence on medicine intake after completion of the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • have a diagnosis of chronic migraine from a clinician or have met the criteria for a chronic migraine diagnosis based on ICHD-3
  • reside in Saskatoon area
  • have a smartphone and internet connection for accessing the MUSE app
  • have no frequent background experience of meditation

排除标准

  • Comorbidity of Raynaud's syndrome or diabetes
  • Current use of a preventative migraine treatment over 6 months

结局指标

主要结局

Migraine Disability

时间窗: 8 weeks

measured by Migraine Disability Assessment Scale (MIDAS)

Headache management self-efficacy

时间窗: 8 weeks

measured by Headache Management Self-Efficacy Scale

Dependence on medicine

时间窗: 8 weeks

measured by Severity of Dependence Scale (SDS)

Migraine Severity

时间窗: 8 weeks

measured by Headache Impact Test-short form (HIT-6)

次要结局

  • Depression(8 weeks)
  • Anxiety(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marla Mickleborough

Dr. Marla Mickleborough

University of Saskatchewan

研究点 (2)

Loading locations...

相似试验